Commitments and Contingencies (Details)		1 Months Ended			3 Months Ended	9 Months Ended
	Feb. 07, 2022 shares	Jul. 31, 2020 USD ($)	Mar. 31, 2020 $ / shares shares	Sep. 30, 2014 USD ($) shares	Mar. 31, 2022 USD ($) m² $ / ft²	Sep. 30, 2021 USD ($)
Other Commitments [Line Items]
Commitments related to agreements					$ 280,000
Maximum payment for commitment milestones					13,200,000
Sub license milestones payments on covered products					$ 200,000
Percentage of sub license income on royalties					15.00%
Office space (in Square Meters) | m²					6,200
Rent expenses per month					$ 11,108
Rent expenses per square foot | $ / ft²					21.50
Cash paid to acquire Hy Biopharma intangible asset				$ 275,000
Issuance of shares for assets (in shares) | shares				184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase				$ 3,750,000
Effective price per share (in Dollars per share) | $ / shares			$ 2.56
Additional Payments						$ 5,000,000.0
Ownership of company outstanding						19.90%
Issuance of common stock | shares	80,646
Hy Biopharma Inc
Other Commitments [Line Items]
Issuance of common stock | shares			1,956,182
Emergent BioSolutions
Other Commitments [Line Items]
Amount of damages to be recovered		$ 19,000,000
Invoices		$ 331,000
Minimum
Other Commitments [Line Items]
Percentage for royalties					2.00%
Percentage of global net sales royalties on covered products					1.50%
Maximum
Other Commitments [Line Items]
Percentage for royalties					3.00%
Percentage of global net sales royalties on covered products					2.50%